Vascular endothelial growth factor level correlates with transforming growth factor-β isoform levels in pleural effusions

Chest

Volumn 118, Issue 6, 2000, Pages 1747-1753

  Cheng, Dong Sheng ^a   Lee, Y C Gary ^a   Rogers, Jeffrey T ^a   Perkett, Elizabeth A ^a   Moyers, J Philip ^a   Rodriguez, R Michael ^a   Light, Richard W ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Pleural effusions; Transforming growth factor ; Vascular endothelial growth factor

Indexed keywords

CYTOKINE; ISOPROTEIN; LACTATE DEHYDROGENASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; VASCULOTROPIN;

ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN TISSUE; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

EID: 0034543478     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.118.6.1747     Document Type: Article

References (29)

1. Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions
2. Vascular endothelial growth factor in pleural fluid
3. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells
4. Some recent advances in the chemistry and biology of transforming growth factor-beta
5. A possible role of TGF-β in the formation of malignant effusions
6. Mechanistic interrelationships between two superfamilies: The steroid/retinoid receptors and transforming growth factor-β
7. Transforming growth factor-beta1 (TGFβ1) and β2 -like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer
8. Local production and localization of transforming growth factor-beta in tuberculous pleurisy
9. Cytokines and soluble receptors in pleural effusions from septic and nonseptic patients
10. Transforming growth factor-β in tissue fibrosis
11. Receptors for transforming growth factor-β (TGFβ) on rat lung fibroblasts have higher affinity for TGFβ1 than for TGF-β2
12. Expression of TGFβ1, β2 and β3 mRNA and protein in the murine lung
13. Pleural effusions: The diagnostic separation of transudations and exudates
14. Isoform specificity of commercially-available anti-TGF-beta antibodies
15. Immunobiology of pleural inflammation: Potential implications for pathogenesis, diagnosis and therapy
16. Vascular endothelial growth factor: Basic biology and clinical implications
17. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease
18. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions
19. Pathogenesis of ascites tumor growth: Vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation
20. Hypoxia augments cytokine (transforming growth factor-beta (TGF-β) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts
21. Vascular endothelial growth factor production is stimulated by gangliosides and TGF-β isoforms in human glioma cells in vitro
22. A single intrapleural injection of transforming growth factor beta-2 produces an excellent pleurodesis in rabbits
23. Comparison of transforming growth factor-β and platelet derived growth factor by normal human mesothelial cells and mesothelioma cell lines
24. The expression of the platelet-derived and transforming growth factor genes in human non-small lung cancer cell lines related to tumor stroma formation in nude mice tumors
25. Transforming growth factor stimulates mammary adenocarcinoma cell invasion and metastatic potential
26. Expression and secretion of type β transforming growth factor by activated human macrophage
27. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth
28. Regulation of alveolar macrophage transforming growth factor-β secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat
29. TGFbeta-2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes